Abrezekimab (Anti-IL-13)

Ask supplier a question | View on supplier's website

Abrezekimab (anti-IL-13) is a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. It can be used in research of asthma. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2454
Sku #	A2454-1mg
Pricing	1mg, $370.00

Feedback